This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.
Figure 2. Percent of Adverse Events after 30 Days for Women Treated for Pelvic Inflammatory Disease by Treatment Group
Source: Ness RB, Soper DE, Holley RL, et al. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) randomized trial. Am J Obstet Gynecol 2002; 186(5):929-37.
Internet Citation: Research in Action, Issue 8 - Figure 2: Research in Action, Issue 8.
September 2002. Agency for Healthcare Research and Quality, Rockville, MD. http://archive.ahrq.gov/research/findings/factsheets/pharmaceutical/rxtherapies/rxriafig2.html
The information on this page is archived and provided for reference purposes only.